Crohn’s disease

Crohn’s disease

Crohn’s disease is an immune-mediated disease in which parts of the digestive tract come under destructive attack. Recurring intestinal ulceration, narrowing and fistula formation are frequent manifestations.

Reponex has developed an innovative drug combination for a new route of administration to improve on the positive but moderate results achieved by systemic administration of these substances while reducing the risk of systemic adverse events.

Indication

Crohn’s disease

The prevalence of Crohn’s disease in the USA and Europe is estimated at approximately3,2 million patients, suffering from this invalidating and quality-of-life-reducing disease.